Singapore markets open in 24 minutes
  • Straits Times Index

    3,286.33
    +15.35 (+0.47%)
     
  • S&P 500

    4,210.24
    +87.77 (+2.13%)
     
  • Dow

    33,309.51
    +535.11 (+1.63%)
     
  • Nasdaq

    12,854.80
    +360.88 (+2.89%)
     
  • BTC-USD

    23,956.48
    +909.46 (+3.95%)
     
  • CMC Crypto 200

    565.69
    +34.47 (+6.49%)
     
  • FTSE 100

    7,507.11
    +18.96 (+0.25%)
     
  • Gold

    1,805.60
    -8.10 (-0.45%)
     
  • Crude Oil

    91.40
    -0.53 (-0.58%)
     
  • 10-Yr Bond

    2.7860
    -0.0110 (-0.39%)
     
  • Nikkei

    27,819.33
    -180.63 (-0.65%)
     
  • Hang Seng

    19,610.84
    -392.60 (-1.96%)
     
  • FTSE Bursa Malaysia

    1,492.33
    -5.35 (-0.36%)
     
  • Jakarta Composite Index

    7,086.24
    -16.64 (-0.23%)
     
  • PSE Index

    6,471.84
    +2.87 (+0.04%)
     

Why BioCryst Pharmaceuticals Topped the Market Today

·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

BioCryst Pharmaceuticals (NASDAQ: BCRX) stock defied the market's gravity on Wednesday by rising incrementally. Although it was a challenging day for stocks in general, with the S&P 500 index sinking by over 1%, BioCryst landed in the black thanks to some encouraging regulatory news. Before market open, BioCryst announced that the Food and Drug Administration (FDA) has granted its BCX9250 investigational drug fast-track designation.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting